Proteomic analyses of limbic regions in neonatal male, female and androgen receptor knockout mice by Anna Zettergren et al.
Zettergren et al. BMC Neurosci  (2017) 18:9 
DOI 10.1186/s12868-016-0332-1
RESEARCH ARTICLE
Proteomic analyses of limbic regions 
in neonatal male, female and androgen receptor 
knockout mice
Anna Zettergren1,2, Sara Karlsson1, Erik Studer1, Anna Sarvimäki1, Petronella Kettunen2,3, Annika Thorsell4, 
Carina Sihlbom4 and Lars Westberg1*
Abstract 
Background: It is well-established that organizational effects of sex steroids during early development are fun-
damental for sex-typical displays of, for example, mating and aggressive behaviors in rodents and other species. 
Male and female brains are known to differ with respect to neuronal morphology in particular regions of the brain, 
including the number and size of neurons, and the density and length of dendrites in nuclei of hypothalamus and 
amygdala. The aim of the present study was to use global proteomics to identify proteins differentially expressed 
in hypothalamus/amygdala during early development (postnatal day 8) of male, female and conditional androgen 
receptor knockout (ARNesDel) male mice, lacking androgen receptors specifically in the brain. Furthermore, verification 
of selected sexually dimorphic proteins was performed using targeted proteomics.
Results: Our proteomic approach, iTRAQ, allowed us to investigate expression differences in the 2998 most abun-
dantly expressed proteins in our dissected tissues. Approximately 170 proteins differed between the sexes, and 38 
proteins between ARNesDel and control males (p < 0.05). In line with previous explorative studies of sexually dimorphic 
gene expression we mainly detected subtle protein expression differences (fold changes <1.3). The protein MARCKS 
(myristoylated alanine rich C kinase substrate), having the largest fold change of the proteins selected from the iTRAQ 
analyses and of known importance for synaptic transmission and dendritic branching, was confirmed by targeted 
proteomics as differentially expressed between the sexes.
Conclusions: Overall, our results provide solid evidence that a large number of proteins show sex differences in their 
brain expression and could potentially be involved in brain sexual differentiation. Furthermore, our finding of a sexu-
ally dimorphic expression of MARCKS in the brain during development warrants further investigation on the involve-
ment in sexual differentiation of this protein.
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Background
There are striking sex differences in many aspects of 
behaviors, not least in social behaviors such as mating 
and displaying of aggression [1]. Most psychiatric dis-
orders also display sex differences in prevalence and/
or symptomatology [2]. Although it is known that both 
sex steroids and sex chromosomes are essential for these 
behavioral differences as well as for sexual dimorphisms 
in brain anatomy and function [3], the knowledge about 
the proteins mediating these effects is sparse. The under-
lying neural circuits of social behaviors are controlled by 
sensory cues as well as by physiological signals, includ-
ing the sex steroids. In rodents, these behaviors differ 
quantitatively as well as qualitatively between males and 
females, and rely on activity in several sexually dimorphic 
regions, e.g. in the amygdala and hypothalamus. In short, 
the medial amygdala neurons receive pheromonal input 
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and subsequently provide afferents to specific hypotha-
lamic nuclei [1, 4, 5], which execute social behaviors, e.g., 
aggression, parental behaviors and mating behaviors.
One of the most important factors responsible for sex-
ual differentiation of the brain is testosterone. By acting 
during critical periods of neural development, testoster-
one and its metabolites cause male and female brains to 
develop differently [6–8]. In males the level of plasma 
testosterone peaks during three different time points; 
in utero, shortly after birth and during puberty [8]. The 
effects of testosterone are mediated by androgen recep-
tors, and after aromatization to 17-β-estradiol, by the 
estrogen receptors (ER-α or ER-β). In rodents, estrogens 
through the ERs are essential for establishing male sexual 
and territorial behaviors whereas testosterone through 
the AR rather modulates the extent of these behavioral 
displays [1, 8]. These steroid receptors are ligand-acti-
vated transcription factors, and through the influence on 
the gene transcription they have the capability to regu-
late the expression levels of many different proteins. In 
addition, the sex steroids can bind to membrane bound 
receptors and thereby activate signal transduction path-
ways associated with changes in cell physiology [9].
Transcriptional effects during development are 
believed to be mainly responsible for sex differences in 
respect to neuronal numbers by differentially inducing 
apoptosis in the sexes [10–15], while other important 
sex differences regarding neuronal morphology, such as 
dendritic spines, dendrite length and the number of syn-
apses are likely modulated both during development as 
well as later in life [11, 16–20]. Moreover, both neuroim-
munological [8] and epigenetic processes [3, 21, 22] are 
thought to contribute to sex differentiation of these neu-
ral circuits.
To understand the origin of sexually dimorphic behav-
iors it is crucial to identify the proteins, which are respon-
sible for the above mentioned structural and functional 
differences, and these could be assumed to be expressed 
differentially in males and females. Sex differences were 
detected already in early brain expression studies of sin-
gle genes and proteins and many were due to sex steroid 
actions [23–25]. Later on, genome-wide studies revealed 
additional mRNA transcripts regulated by sex [26–33], 
and/or sex steroids [22, 34–37]. However, approaches 
such as micro-array technologies allowing large-scale 
analysis of gene/mRNA expression have limitations. For 
example, post-transcriptional events, such as alternative 
mRNA splicing, post-translational protein modifications, 
as well as regulatory mechanisms of protein translation, 
all change the diversity and amount of products that can 
be synthesized from a fixed number of genes, but are not 
detected on the mRNA level analysis. Regarding mRNA 
splicing, both sex-specific and lineage-specific alternative 
splicing has been shown in primates [38]. According to 
one study the mRNA levels explain around 40% of the 
variability in protein levels [39]. In contrast to mRNA-
based expression analysis, proteomics has the advantage 
of studying proteins—the functional molecules of the 
cell [40]. Still, few studies have been performed concern-
ing sex differences in protein expression on large or pro-
teome-wide scale of the mammalian brain [41–44].
The aim of the present study was to identify proteins 
of importance for the sexual differentiation of amygdala 
and hypothalamus during early development. The mas-
culinizing and defeminizing effects of pre- and neona-
tal testosterone are crucial for the sexual differentiation 
of the brain through actions mediated by the androgen 
receptor and the ERs. Therefore, we compared protein 
expression, using an explorative proteomics approach, in 
amygdala/hypothalamus samples from newborn females, 
males and male mice lacking androgen receptors specifi-
cally in the brain (ARNesDel), at a timepoint when the sex 
steroid receptors are known to be robustly expressed (i.e. 
at postnatal day 8, P8) [45]. Since the synaptic connectiv-
ity differs between the sexes and probably partly explains 
sexual dimorphisms in behaviors, one specific focus of 
our study was to explore if levels of synaptic proteins dif-
fer between the sexes.
Methods
Animals
In this experiment 8-day-old (P8) mice were used 
(n  =  24). The mice were either ARflox/y males (n  =  6), 
ARflox/− females (n  =  6), ARNesDel males (n  =  6), or 
ARNesCre males (n = 6). Generation of ARNesDel has been 
described in detail elsewhere [46]. Briefly, mice express-
ing CRE driven by the neuronal Nestin promoter (Jack-
son laboratory, strain #003771) were mated with female 
mice with LoxP sites [47] flanking the second exon of the 
androgen receptor gene. Genotypes were confirmed with 
PCR. Mice were kept in the breeding cage until sacrificed 
at P8. Breeding cages were held in a conventional animal 
facility with 12 h light/12 h dark cycle, lights on at 6.00 
a.m., and given ad libitum access to food and water.
Brain tissue
After decapitation of the mice the brains were removed, 
immediately frozen in liquid nitrogen and stored at 
−80 °C until subsequent use. Dissection of the hypothal-
amus and amygdala was performed by placing the brains 
with the ventral side facing up in a Young Mouse Brain 
Coronal Brain Slicer (matrix) from Zivic Instruments 
(http://www.zivicinstruments.com). Four vertical cuts 
spaced 1  mm apart were made, using razor blades. The 
first cut was made just rostrally of the cerebellum, and 
together with the three following cuts sections between 
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3.39  mm (#17) and 6.27  mm (#41), according to the P6 
series in the Atlas of the developing mouse brain by Paxi-
nos et  al. [48], were generated. The hypothalamus and 
amygdala were subsequently collected from these sec-
tions, using razor blades. The tissue encompassing the 
hypothalamus and amygdala was transferred to Eppen-
dorf tubes at −20 °C and then stored at −80 °C until the 
homogenization process (see below).
Global quantitative proteomic analyses using iTRAQ
Samples were homogenized in lysis buffer [2% SDS in 
50  mM triethylammonium bicarbonate (TEAB)]. Each 
sample (100 µg) and a reference pool (100 µg) containing 
equal amounts of all samples were trypsin digested using 
filter-aided sample preparation (FASP) [49] followed 
by iTRAQ reagent labeling (Applied Biosystems) into 
nine 4-plexed sets. The iTRAQ sets were fractionated 
by Strong Cation Exchange Chromatography (ÄKTA-
system, Amersham-Pharmacia) on a PolySULFOETHYL 
A™ column (100  ×  2.1  mm, 5  µm 300 Å, PolyLC inc.) 
with a gradient from 25 to 500 mM ammonium formate 
(pH 2.8) in 20% ACN over 40 min. Twenty fractions from 
each set were desalted using PepClean C18 spin columns 
according to manufacturer’s instructions (Thermo Fisher 
Scientific), dried down and reconstituted with 15  µL of 
0.1% formic acid in 3% acetonitrile.
The MS and MS/MS were performed on an LTQ Orbit-
rap Velos mass spectrometer interfaced to an Easy-nLC 
II (Thermo Fisher Scientific) in a data-dependent mode. 
Peptides were separated at 200 nL/min using an in-house 
constructed analytical column (200  ×  0.075  mm I.D., 
3 μm C18, Dr. Maisch, Germany) with a gradient from 5 
to 80% acetonitrile in 0.2% formic acid over 90 min. MS 
scans were performed at m/z range 400–1800 and the 
ten most abundant peptides were selected simultaneous 
for MS/MS-fragmentation by HCD for identification and 
quantification.
MS-raw data for each iTRAQ-set were merged for 
relative quantification and identification using Pro-
teome Discoverer version 1.3 (Thermo Fisher Scientific). 
Mascot (Matrix Science) were selected for the database 
search with the parameters Mus musculus Swissprot 
Database version 2.3 (Swiss Institute of Bioinformatics, 
Switzerland), 10  ppm peptide tolerance, 100  mmu MS/
MS tolerance, one missed cleavages, variable methionine 
oxidation and cysteine alkylation modifications, fixed 
iTRAQ-label modifications of N-terminals and lysines 
at 1% False Discovery Rate. For quantification, the ratios 
of the iTRAQ-reporter ion intensities in MS/MS spec-
tra were used. Only unique peptides were considered for 
quantitation.
Welch’s t test was used to compare differences in pro-
tein expression between male and female mice, and 
subsequently between male and ARNesDel male mice. 
Because of the explorative design in this study, a nominal 
p value level of ≤0.05 was used. For all proteins with a p 
value of ≤0.05 in the t test, the fold change (mean male 
ratio versus mean female ratio, or mean male ratio versus 
mean ARNesDel male ratio) was calculated. Proteins with 
missing expression values for more than three samples 
were not included in the analyses. Furthermore, the vari-
ance (SD/mean) in percent was calculated for each pro-
tein, to make sure that this would not exceed the percent 
of up- or down-regulation for a specific protein.
The following proteins were found to be differentially 
expressed in both males versus ARNesDel males and males 
versus ARNesCre males: basal cell adhesion molecule, 
Ras-related protein Rap-1b, microtubule-associated ser-
ine/threonine-protein kinase 3 and lambda-crystallin 
homolog. This means that we cannot exclude that Nes-
Cre by itself may affect the expression levels of these pro-
teins, and, subsequently, they were excluded from the list 
of proteins differentially expressed between males and 
ARNesDel males.
Targeted quantitative proteomic analyses using parallel 
reaction monitoring (PRM)
The selected peptides (JPT peptide Technologies GmbH, 
Berlin, Germany) were unique to the seven different pro-
teins of interest (presented in Table  1) and contained a 
heavy lysine (13C6, 15N2) or arginine (13C6, 15N4). Initially 
calibration curves were prepared by digestion of a rep-
resentative tissue extract together with the labeled pep-
tide as described above, resulting in samples with a final 
concentration of 1 µg/μL total protein containing 3.1, 6.3, 
12.5, 25, 50 or 100  fmol/μL of the labeled peptide. MS 
analyses and evaluation were performed as described 
below. The MS response was found to be linear within 
this concentration range.
The homogenized amygdala/hypothalamus sam-
ples (30 µg each) from the groups of males, females and 
ARNesDel males (the same samples that were used in the 
iTRAQ-analyses) were digested with trypsin as above, 
except that the labeled peptides were added together 
with the trypsin. The samples were spiked with the 
labeled peptides resulting in a concentration close to the 
one determined for the endogenous peptide in the sam-
ple analyzed in the dilution series. The final samples for 
injection contained the labeled peptides in concentra-
tions of 6.3, 12.5, 25, 50 or 100  fmol/µL depending on 
peptide.
The PRM analyses were performed using a Q-Exactive 
mass spectrometer interfaced to an Easy-nLC II (Thermo 
Fisher Scientific). Peptides were separated as above 
except that a gradient from 5 to 80% acetonitrile in 
0.2% formic acid over 40  min was used. For the PRM 
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method, an orbitrap resolution of 35,000 and a quadru-
pole isolation window of 2 Th were used. For MARCKS 
the sequence of the peptide for quantitative analysis was 
AEDGAAPSPSSETPK. The precursor ions of the labeled 
peptide (m/z 726.3492) and endogenous peptide (m/z 
722.3335) were targeted at their 2+ charge in ±4  min 
elution time window and fragmented by HCD.
MS raw data files for each sample were database 
searched and the results were imported into Sky-
line. The most intense fragments of the correspond-
ing pair of endogenous [m/z 1000.4946 (y10), 929.4575 
(y9), 704.3727 (y7)] and labeled [m/z 1008.4796 (y10), 
937.4717 (y9), 753.3869 (y7)] peptides were selected to 
be used for quantification of MARCKS. For the selected 
fragments a minimal degree of interference occurring 
during the elution of the peptides were confirmed. To 
determine the concentration of the endogenous peptide 
from the concentration of the labeled peptide (50  fmol/
µL, quantification based on single point measurement 
concept) the ratio to standard (endogenous/labeled pep-
tide) × concentration labeled peptide was used. For com-
parison of protein expression between groups Welch’s t 
test was used. One male study sample was excluded from 
the PRM study due to interference in the MS-analysis 
that obstructed the quantification.
Results
In the present study, we were able to identify a total of 
2998 proteins in hypothalamus and amygdala of neona-
tal male, female and ARNesDel male mice. After excluding 
proteins lacking expression values for more than three 
samples, 2273 proteins were compared between the 
sexes and 2293 proteins were compared between ARNes-
Del males and male controls. Based on a nominal p value 
level of ≤0.05, 173 proteins were differentially expressed 
in males and females (Additional file  1: Table S1), 
whereas 38 proteins varied between males and ARNes-
Del males (Additional file  2: Table S2). Further analyses 
revealed that 65 of the sexually dimorphic proteins and 
13 of the proteins differentially expressed in males and 
ARNesDel males showed a fold change ≥1.1 (male-biased 
in males versus females or males versus ARNesDel) or 
≤−1.1 (female-biased in males versus females and ARNes-
Del-biased in males versus ARNesDel). The overlap between 
the proteins differentially expressed in males vs. females 
and in males vs. ARNesDel males was found to be small; 
only the proteins Actin (alpha cardiac muscle 1) and Pro-
tein CutA were found to be altered in both comparisons.
Since one specific focus of our study was to explore 
differences in proteins of crucial importance for the syn-
aptic physiology, seven proteins, among the ones with 
a fold change of ≥1.1 or ≤−1.1 and related to synaptic 
connectivity, were chosen for verification analyses with 
targeted proteomics (Table  1). The relation with synap-
tic connectivity relied on the previous literature, as well 
as expert curated gene sets involving genes active in the 
pre- and post-synapse [50, 51], found at http://ctglab.nl/
software/genesets. The result of the targeted proteom-
ics analysis verified that one of the proteins, MARCKS 
(myristoylated alanine rich C kinase substrate), was dif-
ferentially expressed in males and females. The concen-
trations of the MARCKS were significantly changed in 
the male and ARNesDel male groups compared with the 
female group (p = 0.01 for both comparisons, see Fig. 1). 
In line with our results from the iTRAQ analyses, no 
significant difference in MARCKS expression levels was 
found between the male and ARNesDel male groups.
Discussion
To understand more about the molecular mecha-
nisms underlying sexual dimorphisms in behavior and 
brain function, we here compared protein expression 
Table 1 Results from iTRAQ analyses for the proteins included in targeted proteomics
a Fold changes between males and females. Positive values represent male-biased proteins and negative values represent female-biased proteins
b Proteins differentially expressed (p ≤ 0.05) in males and females
Proteins Uniprot accession nr Fold changea p valueb
Scaffolders and adaptors
 Neurobeachin Q9EPN1 1.09 0.022
G-proteins and modulators
 Neuromodulin P06837 −1.1 0.002
 Septin-7 O55131 −1.1 0.002
Cytoskeletal and cell adhesion
 Myristoylated alanine-rich C-kinase substrate P26645 −1.22 0.007
 Neurochondrin Q9Z0E0 1.12 0.049
Transcription and translation
 General transcription factor II-I Q9ESZ8 1.15 0.049
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in hypothalamus/amygdala from neonatal males and 
females. Our explorative proteomic approach allowed 
us to investigate differences in approximately 2300 of the 
most highly-expressed proteins in our dissected tissues. 
No large changes in any specific protein were revealed, 
but many proteins (>170) displayed small expression 
differences between the sexes (fold changes of less than 
1.34 or more than −1.31). Importantly, considering that 
approximately 2300 proteins were compared between 
groups about 115 proteins of these should be expected 
to be false positives at the selection threshold p = 0.05. 
Interestingly however, the MARCKS protein was verified 
as differentially expressed between the sexes using tar-
geted proteomics.
There is consistent evidence for sex differences in mor-
phology and synaptic connectivity in the hypothalamus, 
the amygdala as well as in many other brain regions 
[11]. Therefore it is interesting that the synaptic pro-
tein MARCKS was identified as sexually dimorphic with 
both our proteomic approaches, iTRAQ and targeted 
proteomics. MARKCS is a cellular substrate for protein 
kinase C and is highly expressed in the brain, especially 
during development [52, 53]. MARCKS has been shown 
to be of importance for synaptic signaling [54] and plas-
ticity [55] and is necessary for normal mouse brain devel-
opment [52]. Previous studies have mainly focused on the 
role of this protein in processes related to memory [56, 
57] and learning [53]. The present study is the first to 
report sex differences in brain protein levels of MARCKS 
and this result may provide knowledge regarding the 
molecular mechanisms involved in the well-established 
sex differences with respect to, for example, dendritic 
spines, dendrite length and the number of synapses [11]. 
Future studies should confirm our finding of sexually 
dimorphic expression of MARCKS in neonates, but also 
extend the investigations to other developmental stages 
and more specific nuclei of the limbic system.
The subtle magnitudes of the sex differences revealed in 
our study are very much in line with previous exploratory 
studies of sexually dimorphic gene expression [27, 33, 58–
60]. For example, in a microarray study by Yang et al. [27] 
613 of 4508 brain expressed genes differed by >onefold 
between the sexes, and 37 of those 613 genes displayed 
a fold difference of >1.2. Likewise, also in a recent study 
of postmortem human brains from men and women only 
subtle gene expression differences were detected [61]. 
Small expression differences between the sexes were 
also confirmed on the protein level in a recent study of 
approximately 100 proteins in several brain regions [41] 
showing that only 2 of the 51 sexually dimorphic proteins 
differed by >30%. As previously suggested [60], this may 
indicate that differences between the sexes in brain func-
tion and behavior may arise from combinatorial effects 
of a large number of proteins. Moreover, recent studies 
indicate that the sexually dimorphic and hormone regu-
lated gene expression may mainly be restricted to specific 
neurons of certain brain nuclei [22, 37, 59, 62]. Hence, 
our choice of tissue dissection comprising the many 
nuclei and neuronal types of hypothalamus and amygdala 
may have compromised the possibility to reveal larger 
differences in protein expression. Furthermore, as the 
present study did not include samples from brain areas 
not expressing sex steroid receptors we cannot evaluate if 
the subtle sex differences extend to areas of the brain not 
influenced by gonadal hormones. Thus, inclusion of such 
control samples in future large-scale studies is warranted. 
Taken together, future studies should attempt to investi-
gate protein expression in several specifically dissected 
brain regions in large sets of samples.
To our knowledge, no previous studies have compared 
expression differences between ARNesDel mice and con-
trols on a genome-wide or proteome-wide basis. How-
ever, a number of studies have investigated the effects of 
sex steroid treatment on gene expression in normal mice 
[22, 34–37, 63]. By using the ARNesDel mouse line, known 
to have no or low expression of androgen receptors in the 
brain already during embryonal development [45, 46, 64–
66], it was possible to specifically investigate if differen-
tially expressed proteins were regulated by the androgen 
receptor. Surprisingly, only small differences of less than 
40 proteins were seen between males expressing and not 
Fig. 1 Protein expression levels of MARCKS based on results from 
targeted proteomics. Due to interference in the MS-analysis that 
obstructed the quantification, one male sample was excluded from 
this experiment. Comparisons of protein expression levels of MARCKS 
between male (n = 5) and female (n = 6) mice, and subsequently 
between female and ARNesDel male (n = 6) mice, at postnatal day 8, 
show a significantly higher expression in females compared to both 
males and ARNesDel males, **p ≤ 0.01. The difference between males 
and ARNesDel males was non-significant (p = 0.72). The comparisons 
were performed using Welch’s t test
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expressing androgen receptors in the brain, indicating 
that the influence of the androgen receptor on protein 
levels in the investigated brain areas at the age of P8 is 
limited. Juntti et al. [45] showed that the androgen recep-
tor is expressed from P7, but our data may indicate that 
its effects on protein expression occur later on.
In the present study we used iTRAQ (isobaric tags for 
relative and absolute quantitation) for unbiased prot-
eomics analysis that allows simultaneous relative quan-
tification of proteins in multiple samples. The technique 
offers reduced systematic error and increased efficiency 
leading to higher sensitivity [67]. For absolute quantifica-
tion of the seven selected proteins, targeted quantitative 
proteomics using parallel reaction monitoring (PRM) 
was performed. Isotopically labelled peptides containing 
unique sequences for the selected proteins were spiked 
at known concentrations into the samples allowing abso-
lute quantification of the peptides and their correspond-
ing proteins. During the PRM analysis the fragment ions 
of the endogenous and its isotopically labelled peptides 
were monitored simultaneous at high resolution, which 
reduces interferences and significantly enhances the 
selectivity of the method. Using PRM, which also is a 
more sensitive method compared to iTRAQ, for investi-
gations of proteins differentially expressed in the global 
proteomic analysis, showed that only fold changes over 
20% could be verified. This result suggests that fold 
changes around 10% detected in the iTRAQ analysis were 
difficult to verify due to our relatively small sample size. 
Furthermore, although iTRAQ detects a large number of 
proteins (up to about 3000 in the tissues investigated in 
this study), there are most likely relevant proteins which 
are affected by sex or androgen receptors but which 
remain undetected by using this approach.
Conclusions
Our results may suggest that a large number of proteins 
could be involved in the sexual differentiation of the 
brain, since we observed many subtle but no large sex dif-
ferences for single proteins. Future analyses using more 
sensitive detection methods of samples from specific 
brain nuclei from large number of samples may how-
ever modify this view. The importance of our finding of 
a sexual dimorphic expression of MARCKS for sexual 
differentiation of the brain needs to be clarified by future 
research.
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